Your browser doesn't support javascript.
loading
Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration.
Rademacher, Katerina; Doric, Zak; Haddad, Dominik; Mamaligas, Aphroditi; Liao, Szu-Chi; Creed, Rose B; Kano, Kohei; Chatterton, Zac; Fu, Yuhong; Garcia, Joseph H; Vance, Victoria; Sei, Yoshitaka; Kreitzer, Anatol; Halliday, Glenda M; Nelson, Alexandra B; Margolis, Elyssa B; Nakamura, Ken.
Afiliação
  • Rademacher K; Gladstone Institute for Neurological Disease, Gladstone Institutes, San Francisco, CA.
  • Doric Z; Graduate Program in Neuroscience, University of California San Francisco, San Francisco , CA.
  • Haddad D; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD.
  • Mamaligas A; Gladstone Institute for Neurological Disease, Gladstone Institutes, San Francisco, CA.
  • Liao SC; Graduate Program in Neuroscience, University of California San Francisco, San Francisco , CA.
  • Creed RB; Gladstone Institute for Neurological Disease, Gladstone Institutes, San Francisco, CA.
  • Kano K; Gladstone Institute for Neurological Disease, Gladstone Institutes, San Francisco, CA.
  • Chatterton Z; Gladstone Institute for Neurological Disease, Gladstone Institutes, San Francisco, CA.
  • Fu Y; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD.
  • Garcia JH; Department of Nutritional Sciences & Toxicology, University of California Berkeley, Berkeley, CA.
  • Vance V; Endocrinology Graduate Program, University of California Berkeley, Berkeley, CA.
  • Sei Y; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD.
  • Kreitzer A; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA.
  • Halliday GM; Gladstone Institute for Neurological Disease, Gladstone Institutes, San Francisco, CA.
  • Nelson AB; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD.
  • Margolis EB; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD.
  • Nakamura K; Brain and Mind Centre, Faculty of Medicine and Health, School of Medical Sciences, University of Sydney, Sydney, Australia.
bioRxiv ; 2024 May 13.
Article em En | MEDLINE | ID: mdl-38645054
ABSTRACT
Parkinson's disease (PD) is characterized by the death of substantia nigra (SNc) dopamine (DA) neurons, but the pathophysiological mechanisms that precede and drive their death remain unknown. The activity of DA neurons is likely altered in PD, but we understand little about if or how chronic changes in activity may contribute to degeneration. To address this question, we developed a chemogenetic (DREADD) mouse model to chronically increase DA neuron activity, and confirmed this increase using ex vivo electrophysiology. Chronic hyperactivation of DA neurons resulted in prolonged increases in locomotor activity during the light cycle and decreases during the dark cycle, consistent with chronic changes in DA release and circadian disturbances. We also observed early, preferential degeneration of SNc projections, recapitulating the PD hallmarks of selective vulnerability of SNc axons and the comparative resilience of ventral tegmental area axons. This was followed by eventual loss of midbrain DA neurons. Continuous DREADD activation resulted in a sustained increase in baseline calcium levels, supporting an important role for increased calcium in the neurodegeneration process. Finally, spatial transcriptomics from DREADD mice examining midbrain DA neurons and striatal targets, and cross-validation with human patient samples, provided insights into potential mechanisms of hyperactivity-induced toxicity and PD. Our results thus reveal the preferential vulnerability of SNc DA neurons to increased neural activity, and support a potential role for increased neural activity in driving degeneration in PD.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article